Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin in primary axillary hyperhidrosis
NCT03760198Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Aug 2018
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Meditoxin in primary axillary hyperhidrosis (PAH), sponsored by Medytox Inc.. Started Aug 2018; status: completed.
02
Drugs
Meditoxin
03
Conditions
primary axillary hyperhidrosis (PAH)
Beyond the preview
Go deeper on NCT03760198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03760198.